BlackSwanAlert
  • Headlines
  • Subscribe
  • Contact Us
Select Page
Elon Musk’s Neuralink wins FDA approval for human study of brain implants

Elon Musk’s Neuralink wins FDA approval for human study of brain implants

by Reuters | May 26, 2023 | Business, Health, Science, Top News, US

By Rachael Levy, Marisa Taylor and Akriti Sharma (Reuters) -Elon Musk’s Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the brain-implant startup as it faces U.S. probes over...
AI in Washington’s crosshairs but consensus far from certain

AI in Washington’s crosshairs but consensus far from certain

by Reuters | May 15, 2023 | Business, Entertainment and Lifestyle, Health, Politics, Technology, Top News

By Diane Bartz and Jeffrey Dastin WASHINGTON (Reuters) -U.S. lawmakers are grappling with what guardrails to put around burgeoning artificial intelligence, but months after ChatGPT got Washington’s attention, consensus is far from certain. Interviews with a U.S....
Pfizer CEO calls US drug price plan ‘negotiation with a gun to your head’

Pfizer CEO calls US drug price plan ‘negotiation with a gun to your head’

by Reuters | May 12, 2023 | Business, Health, US

By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program “negotiation with a gun to your head” and said he expects drugmakers to sue in an...
At Musk’s brain-chip startup, animal-testing panel is rife with potential conflicts

At Musk’s brain-chip startup, animal-testing panel is rife with potential conflicts

by Reuters | May 9, 2023 | Business, Health, Technology, Top News

By Rachael Levy and Marisa Taylor (Reuters) – Elon Musk’s brain-implant venture has filled an animal-research oversight board with company insiders who may stand to benefit financially as the firm reaches development goals, according to company documents and...
One-third of US nurses plan to quit profession – report

One-third of US nurses plan to quit profession – report

by Reuters | May 1, 2023 | Business, Economy, Health, Top News, US

By Khushi Mandowara and Leroy Leo (Reuters) – Almost a third of the nurses in the United States are considering leaving their profession after the COVID-19 pandemic left them overwhelmed and fatigued, according to a survey. The survey of over 18,000 nurses,...
Rodents beware: New York City hires first ‘rat czar’

Rodents beware: New York City hires first ‘rat czar’

by Reuters | Apr 12, 2023 | Environment, Health, Oddly Enough, Politics, Science, Top News

By Joseph Ax (Reuters) – New York City’s unending war on rats has a new commanding general. Mayor Eric Adams on Wednesday announced that Kathleen Corradi, an education department employee, has been appointed New York’s first-ever “rat czar,”...
« Older Entries
  • Full Disclaimer
  • Terms of Use
  • Privacy Policy

Copyright © 2017 - 2021 BlackSwanAlert.com All Rights Reserved

This page contains links to products not offered by BLACKSWANALERT.COM. In exchange for listing these links, we are likely to receive commission for purchases made through these links.

BLACKSWANALERT.COM is provided to you for informational purposes only and should not be construed as an offer to buy or sell a particular security or a solicitation of offers to buy or sell a particular security. BLACKSWANALERT.COM may make available certain information related to trading strategies and stock prices for educational and information purposes only; any information made available should not be construed as an endorsement, recommendation or sponsorship of any company or security.

We do not offer investment advice or advocate the purchase, holding or sale of any security or investment by any user of our materials or viewer of any of information videos. We do not provide any legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular interment, security, or informational source. By visiting this site or using the training materials, you acknowledge and agree that any reliance upon the content or data available through BLACKSWANALERT.COM is at your own sole risk. You are strongly advised to use your own judgment, research, and consult a professional advisor.

The information is generic in nature and not targeted to individuals or individual circumstances. We offer our opinion and not specific advice. No professional relationship is formed by visiting this site, viewing its contents, or by purchasing a specific product or service we offer. No fiduciary relationship has been established, nor will one be established at any time.

Results are not typical. Trading securities may not be suitable for all users of this information. Trading stocks and investing in the stock market is inherently risky. You can lose money trading stocks. Do not invest money you cannot afford to lose. Before deciding to trade, you should ensure that you understand the risks involved and take into account your level of experience. You should seek independent advice, if necessary. You, the visitor to this site and user of our products and services, are solely responsible for any losses, financial or otherwise, as a result of trading stocks. Under all circumstances, you, and not BLACKSWANALERT.COM, assume the entire cost and all risks involved with trading any stock based on any information procured herein. Any views expressed on this site were prepared based upon the information available at the time such views were expressed. Changed or additional information could cause such views to change. The contributors of this site’s information may have a financial interest in many of the stocks discussed herein.